The arguments proposed by Dr. Brown for the use of 
The causes of the increase are less clear. As noted by Dr. Brown, patients with more severe depression and patients with chronic depression have been shown to have a lessened placebo responsivity than patients with more acute depression and less severe depressive illnesses. Dr. Brown suggests that the increase in placebo responsivity may be related to fewer side effects associated with the new drugs and resulting less chance that the investigator will be able to determine drug versus placebo treatment (bias effect). An alternate ex planation is that patients with depression are coming 
